133 related articles for article (PubMed ID: 24853574)
1. Comments on: "allergen immunotherapy as a drug: the new deal of grass allergen tablets from clinical trials to current practice".
de Beaumont O; Yalaoui T
Eur Ann Allergy Clin Immunol; 2014 May; 46(3):125-6. PubMed ID: 24853574
[No Abstract] [Full Text] [Related]
2. Allergen immunotherapy as a drug: the new deal of grass allergen tablets from clinical trials to current practice.
Manzotti G; Lombardi C
Eur Ann Allergy Clin Immunol; 2013 Apr; 45(2):34-42. PubMed ID: 23821831
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial shows sublingual immunotherapy to be effective for treatment of children with grass pollen allergy.
Wilkinson J
Immunotherapy; 2012 Nov; 4(11):1091-2. PubMed ID: 23194357
[No Abstract] [Full Text] [Related]
4. Reply: To PMID 23821831.
Manzotti G; Lombardi C
Eur Ann Allergy Clin Immunol; 2014 May; 46(3):127-8. PubMed ID: 24853575
[No Abstract] [Full Text] [Related]
5. SQ-standardised grass tablet sublingual immunotherapy: persistent clinical benefit and progressive immunological changes during three years treatment.
Durham SR
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():121-7; discussion 127-31. PubMed ID: 20799452
[No Abstract] [Full Text] [Related]
6. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
7. Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet.
Nelson H; Lehmann L; Blaiss MS
Curr Med Res Opin; 2012 Jun; 28(6):1043-51. PubMed ID: 22502864
[TBL] [Abstract][Full Text] [Related]
8. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
Wolthers OD; Høst A; Frederiksen B; Halken S
Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy.
Frew AJ
N Engl J Med; 2008 May; 358(21):2259-64. PubMed ID: 18499568
[No Abstract] [Full Text] [Related]
10. Sublingual immunotherapy: allergen specific or placebo effect?
Kette F; Smith W
J Allergy Clin Immunol; 2011 Aug; 128(2):430; author reply 430-2. PubMed ID: 21665261
[No Abstract] [Full Text] [Related]
11. Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?
Witten M; Malling HJ; Blom L; Poulsen BC; Poulsen LK
J Allergy Clin Immunol; 2013 Nov; 132(5):1248-1252.e5. PubMed ID: 24035151
[No Abstract] [Full Text] [Related]
12. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous SCIT with 2 separate allergen extracts demonstrates comparable safety compared to SCIT with a single allergen extract.
Röder A; Darrelmann N; Klingenberg W; Krüll M; Suttorp N; Noga O
J Investig Allergol Clin Immunol; 2009; 19(6):512-3. PubMed ID: 20128433
[No Abstract] [Full Text] [Related]
14. Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis.
Agostinis F; Forti S; Di Berardino F
Allergy; 2010 Mar; 65(3):410-1. PubMed ID: 19804450
[No Abstract] [Full Text] [Related]
15. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
[TBL] [Abstract][Full Text] [Related]
16. Is oral immunotherapy too good to be true?
Ledford DK
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):1-2. PubMed ID: 14756456
[No Abstract] [Full Text] [Related]
17. Ultra-short-course booster allergen immunotherapy.
Pfaar O; Pieper-Fürst U; Mösges R
Immunotherapy; 2018 Jun; 10(7):525-528. PubMed ID: 29562789
[No Abstract] [Full Text] [Related]
18. An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergy.
Rask C; Lund L; Lund G; Heydenreich B; Wurtzen P; Bellinghausen I; Saloga J; Lund K
Clin Exp Allergy; 2012 Sep; 42(9):1356-68. PubMed ID: 22925322
[TBL] [Abstract][Full Text] [Related]
19. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.
Senna GE; Calderon M; Milani M
Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646
[TBL] [Abstract][Full Text] [Related]
20. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage.
Durham SR; Riis B
Allergy; 2007 Aug; 62(8):954-7. PubMed ID: 17620075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
